# Alpha Lipoic Acid Supplementation and Metabolic Syndrome

> **NCT03589690** · NA · UNKNOWN · sponsor: **Dr. B.Abbasi** · enrollment: 44 (estimated)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Alpha lipoic acid
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03589690
- **Lead sponsor:** Dr. B.Abbasi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-25
- **Primary completion:** 2019-04-25
- **Final completion:** 2019-07-25
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2018-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03589690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03589690, "Alpha Lipoic Acid Supplementation and Metabolic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03589690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*